Cellosaurus logo
expasy logo

Cellosaurus SKG-IIIa (CVCL_1704)

[Text version]
Cell line name SKG-IIIa
Synonyms SKG-IIIA; SKG IIIa; SKGIIIA; SKG-3a; SKG3A; SKG3a
Accession CVCL_1704
Resource Identification Initiative To cite this cell line use: SKG-IIIa (RRID:CVCL_1704)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Population: Japanese.
Microsatellite instability: Stable (MSS) (Sanger).
Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
Sequence variations
  • Mutation; HGNC; 11998; TP53; Simple; p.Lys132Asn (c.396G>C); ClinVar=VCV000376624; Zygosity=Heterozygous (Cosmic-CLP=930298; DepMap=ACH-002020).
Genome ancestry Source: PubMed=30894373

Origin% genome
African0.18
Native American0
East Asian, North84.88
East Asian, South14.94
South Asian0
European, North0
European, South0
Disease Human papillomavirus-related cervical squamous cell carcinoma (NCIt: C27676)
Squamous cell carcinoma of the cervix uteri (ORDO: Orphanet_213767)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_2795 ! SKG-IIIb
Sex of cell Female
Age at sampling 38Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP=930298; JCRB=IFO50310; JCRB=JCRB0232; PubMed=25877200; RCB=RCB1892; TKG=TKG 0462

Markers:
AmelogeninX
CSF1PO11,12
D2S133819,26
D3S135816
D5S81810,11
D7S82010 (JCRB=JCRB0232)
10,12 (Cosmic-CLP=930298; PubMed=25877200; JCRB=IFO50310; RCB=RCB1892; TKG=TKG 0462)
D8S117911,15
D13S31712
D16S5399,11
D18S5116
D19S43313
D21S1131.2,32.2
FGA21,22
Penta D9
Penta E10
TH016,9
TPOX8,11
vWA16

Run an STR similarity search on this cell line
Publications

PubMed=6600963
Nozawa S., Udagawa Y., Ohta H., Kurihara S., Fishman W.H.
Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin beta-subunit, and pregnancy-specific beta 1-glycoprotein phenotypes.
Cancer Res. 43:1748-1760(1983)

PubMed=6699456
Udagawa Y., Nozawa S., Tsukazaki K., Ohta H., Akiba T., Kurihara S.
Biological properties of two newly established cell lines (SKG-3a,3b) from a human uterine cervical epidermoid carcinoma.
Nihon Sanka Fujinka Gakkai Zasshi 36:237-246(1984)

PubMed=8380785; DOI=10.1006/gyno.1993.1016
Iwasaka T., Oh-uchida M., Matsuo N., Yokoyama M., Fukuda K., Hara K., Fukuyama K., Hori K., Sugimori H.
Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Gynecol. Oncol. 48:104-109(1993)

CLPUB00481
Kuno H., Yoshida T.
Detection of human papillomavirus types 16, 18, and 33 in cell lines derived from human genital organs by polymerase chain reaction.
Res. Commun. Inst. Ferment. 18:6-12(1997)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=15099960; DOI=10.1016/j.ygyno.2004.02.012
Fujimoto T., Nishikawa A., Iwasaki M., Akutagawa N., Teramoto M., Kudo R.
Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.
Gynecol. Oncol. 93:446-453(2004)

PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113
Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225
de Lourdes Zuniga-Martinez M., Lopez-Mendoza C.M., Tenorio-Salazar J., Garcia-Carranca A.M., Cerbon-Cervantes M.A., Alcantara-Quintana L.E.
Establishment, authenticity, and characterization of cervical cancer cell lines.
Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line collections (Providers) JCRB; IFO50310
JCRB; JCRB0232
RCB; RCB1892
TKG; TKG 0462
Cell line databases/resources CLO; CLO_0050923
cancercelllines; CVCL_1704
Cell_Model_Passport; SIDM00381
Cosmic-CLP; 930298
DepMap; ACH-002020
LINCS_LDP; LCL-1804
Biological sample resources BioSample; SAMN01821739
BioSample; SAMN03470894
BioSample; SAMN03471660
Chemistry resources ChEMBL-Cells; CHEMBL3308786
ChEMBL-Targets; CHEMBL1075581
GDSC; 930298
PharmacoDB; SKGIIIa_1417_2019
PubChem_Cell_line; CVCL_1704
Encyclopedic resources Wikidata; Q54954734
Gene expression databases ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-3610
GEO; GSM1670429
Polymorphism and mutation databases Cosmic; 877461
Cosmic; 930298
Cosmic; 1152539
Cosmic; 1995630
IARC_TP53; 27576
Proteomic databases PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
Entry history
Entry creation04-Apr-2012
Last entry update02-May-2024
Version number37